Strs Ohio Biomarin Pharmaceutical Inc Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Strs Ohio holds 16,000 shares of BMRN stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,000

Previous 16,000 -0.0%

Holding current value

$1.05 Million

Previous $1.32 Million 14.65%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$86.68 - $100.3 $1.24 Million - $1.44 Million	-14,346 Reduced 47.27%	16,000 $1.39 Million
Q1 2023 Aug 02, 2023	BUY	$87.74 - $117.27 $1.26 Million - $1.68 Million	14,346 Added 89.66%	30,346 $2.95 Million
Q1 2023 Apr 27, 2023	BUY	$87.74 - $117.27 $1.26 Million - $1.68 Million	14,346 Added 89.66%	30,346 $2.95 Million
Q4 2022 Jan 26, 2023	SELL	$80.93 - $108.63 $1.05 Million - $1.41 Million	-12,959 Reduced 44.75%	16,000 $1.66 Million
Q3 2022 Oct 27, 2022	BUY	$82.16 - $96.94 $1.06 Million - $1.26 Million	12,959 Added 80.99%	28,959 $2.45 Million
Q2 2022 Jul 25, 2022	SELL	$71.48 - $86.85 $1.32 Million - $1.61 Million	-18,493 Reduced 53.61%	16,000 $1.33 Million
Q1 2022 Apr 21, 2022	BUY	$74.28 - $92.69 $1.03 Million - $1.29 Million	13,909 Added 67.57%	34,493 $2.66 Million
Q4 2021 Jan 24, 2022	BUY	$71.72 - $91.47 $9,467 - $12,074	132 Added 0.65%	20,584 $1.82 Million
Q3 2021 Oct 22, 2021	SELL	$74.77 - $85.47 $53,759 - $61,452	-719 Reduced 3.4%	20,452 $1.58 Million
Q2 2021 Jul 26, 2021	SELL	$75.51 - $84.79 $282,482 - $317,199	-3,741 Reduced 15.02%	21,171 $1.77 Million
Q1 2021 Apr 23, 2021	SELL	$74.73 - $90.69 $32,283 - $39,178	-432 Reduced 1.7%	24,912 $1.88 Million
Q4 2020 Jan 25, 2021	SELL	$72.61 - $90.2 $3.08 Million - $3.82 Million	-42,357 Reduced 62.56%	25,344 $2.22 Million
Q3 2020 Dec 14, 2020	SELL	$71.87 - $131.03 $25.4 Million - $46.2 Million	-352,811 Reduced 83.9%	67,701 $5.15 Million
Q2 2020 Jul 23, 2020	BUY	$79.55 - $124.22 $30.2 Million - $47.1 Million	379,327 Added 921.03%	420,512 $51.9 Million
Q2 2019 Jul 25, 2019	SELL	$80.35 - $93.9 $11.7 Million - $13.7 Million	-145,600 Reduced 77.95%	41,185 $3.53 Million
Q3 2018 Oct 19, 2018	BUY	$93.92 - $105.72 $4.62 Million - $5.2 Million	49,200 Added 35.76%	186,785 $18.1 Million
Q2 2018 Aug 06, 2018	SELL	$76.01 - $99.03 $3.97 Million - $5.17 Million	-52,228 Reduced 27.52%	137,585 $13 Million
Q1 2018 Apr 20, 2018	SELL	$77.67 - $92.63 $16.3 Million - $19.5 Million	-210,483 Reduced 52.58%	189,813 $15.4 Million
Q4 2017 Jan 23, 2018	SELL	$80.76 - $95.13 $16.4 Million - $19.3 Million	-203,224 Reduced 33.67%	400,296 $35.7 Million
Q3 2017 Oct 23, 2017	BUY	$80.6 - $94.95 $48.6 Million - $57.3 Million	603,520	603,520 $56.2 Million

Others Institutions Holding BMRN

# of Institutions

629

Shares Held

178M

Call Options Held

1.98M

Put Options Held

1.17M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account